|
|||||
|
|
(S)-oxybutynin (Sepracor) |
|
| Authors: | Dmochowski Roger R |
| Institution: | Department of Urology, Vanderbilt University, Nashville, TN 37232, USA. roger.dmochowski@mcmail.vanderbilt.edu |
| Abstract: | Sepracor is developing (S)-oxybutynin, a single-isomer version of Alza's Ditropan (racemic oxybutynin), a muscarinic acetylcholine receptor antagonist, as a potential treatment for urinary incontinence. |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |